Page last updated: 2024-10-17

3,4-dihydroxyphenylacetic acid and Gelineau Syndrome

3,4-dihydroxyphenylacetic acid has been researched along with Gelineau Syndrome in 9 studies

3,4-Dihydroxyphenylacetic Acid: A deaminated metabolite of LEVODOPA.
(3,4-dihydroxyphenyl)acetic acid : A dihydroxyphenylacetic acid having the two hydroxy substituents located at the 3- and 4-positions. It is a metabolite of dopamine.
dihydroxyphenylacetic acid : A dihydroxy monocarboxylic acid consisting of phenylacetic acid having two phenolic hydroxy substituents.

Research Excerpts

ExcerptRelevanceReference
"The other had the sole symptom of excessive daytime sleepiness, confirmed by sleep latency tests, which was unaccompanied by systemic illness."1.27Cerebrospinal fluid monoamine metabolites in narcolepsy and hypersomnia. ( Barchas, JD; Berger, PA; Faull, KF; Guilleminault, C, 1983)

Research

Studies (9)

TimeframeStudies, this research(%)All Research%
pre-19906 (66.67)18.7374
1990's1 (11.11)18.2507
2000's1 (11.11)29.6817
2010's0 (0.00)24.3611
2020's1 (11.11)2.80

Authors

AuthorsStudies
Krief, S1
Berrebi-Bertrand, I1
Nagmar, I1
Giret, M1
Belliard, S1
Perrin, D1
Uguen, M1
Robert, P1
Lecomte, JM1
Schwartz, JC1
Finance, O1
Ligneau, X1
Faull, KF5
Barchas, JD4
Foutz, AS3
Dement, WC5
Holman, RB2
Mefford, IN1
Baker, TL1
Boehme, R1
Ciaranello, RD2
Guilleminault, C2
Berger, PA1
Nishino, S1
Fujiki, N1
Ripley, B1
Sakurai, E1
Kato, M1
Watanabe, T1
Mignot, E1
Yanai, K1
Faull, K1
Miller, JD1
Bowersox, SS2
Thiemann, S1
King, RJ1
Kilduff, TS1
Zeller-DeAmicis, L1

Other Studies

9 other studies available for 3,4-dihydroxyphenylacetic acid and Gelineau Syndrome

ArticleYear
Pitolisant, a wake-promoting agent devoid of psychostimulant properties: Preclinical comparison with amphetamine, modafinil, and solriamfetol.
    Pharmacology research & perspectives, 2021, Volume: 9, Issue:5

    Topics: 3,4-Dihydroxyphenylacetic Acid; Adrenergic Uptake Inhibitors; Amphetamine; Animals; Carbamates; Corp

2021
Monoamine metabolite concentrations in the cerebrospinal fluid of normal and narcoleptic dogs.
    Brain research, 1982, Jun-17, Volume: 242, Issue:1

    Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Biogenic Amines; Dogs; Homovanillic Acid; Humans; Hydroxyin

1982
Narcolepsy: biogenic amine deficits in an animal model.
    Science (New York, N.Y.), 1983, May-06, Volume: 220, Issue:4597

    Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Brain Chemistry; Disease Models, Animal; Dogs; Dopamine; Ep

1983
Cerebrospinal fluid monoamine metabolites in narcolepsy and hypersomnia.
    Annals of neurology, 1983, Volume: 13, Issue:3

    Topics: 3,4-Dihydroxyphenylacetic Acid; Adult; Aged; Amino Acids; Disorders of Excessive Somnolence; Female;

1983
Decreased brain histamine content in hypocretin/orexin receptor-2 mutated narcoleptic dogs.
    Neuroscience letters, 2001, Nov-09, Volume: 313, Issue:3

    Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Brain; Brain Chemistry; Cerebral Cortex; Chromatography, Hi

2001
The concentrations of amine metabolites in cerebrospinal fluid from normal and narcoleptic dogs [proceedings].
    The Journal of physiology, 1979, Volume: 296

    Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Dogs; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid;

1979
CNS monoamines and their metabolites in canine narcolepsy: a replication study.
    Brain research, 1990, Feb-12, Volume: 509, Issue:1

    Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Brain; Disease Models, Animal; Dogs; Dopamine; Hydroxyindol

1990
Monoamine interactions in narcolepsy and hypersomnia: a preliminary report.
    Sleep, 1986, Volume: 9, Issue:1 Pt 2

    Topics: 3,4-Dihydroxyphenylacetic Acid; Biogenic Amines; Brain; Dopamine; Homovanillic Acid; Humans; Hydroxy

1986
Brain dopamine receptor levels elevated in canine narcolepsy.
    Brain research, 1987, Jan-27, Volume: 402, Issue:1

    Topics: 3,4-Dihydroxyphenylacetic Acid; Amygdala; Animals; Brain Chemistry; Caudate Nucleus; Dogs; Dopamine;

1987